Advances in surgical management for locally recurrent rectal cancer: How far have we come?
- PMID: 28694657
- PMCID: PMC5483491
- DOI: 10.3748/wjg.v23.i23.4170
Advances in surgical management for locally recurrent rectal cancer: How far have we come?
Abstract
Locally recurrent rectal cancer (LRRC) is a complex disease with far-reaching implications for the patient. Until recently, research was limited regarding surgical techniques that can increase the ability to perform an en bloc resection with negative margins. This has changed in recent years and therefore outcomes for these patients have improved. Novel radical techniques and adjuncts allow for more radical resections thereby improving the chance of negative resection margins and outcomes. In the past contraindications to surgery included anterior involvement of the pubic bone, sacral invasions above the level of S2/S3 and lateral pelvic wall involvement. However, current data suggests that previously unresectable cases may now be feasible with novel techniques, surgical approaches and reconstructive surgery. The publications to date have only reported small patient pools with the research conducted by highly specialised units. Moreover, the short and long-term oncological outcomes are currently under review. Therefore although surgical options for LRRC have expanded significantly, one should balance the treatment choices available against the morbidity associated with the procedure and select the right patient for it.
Keywords: Pelvic exenteration; Pelvic sidewall; Radical resection; Recurrent rectal cancer; Sacrectomy.
Conflict of interest statement
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Figures
Comment in
-
Extended pelvic side wall excision for locally advanced rectal cancers.World J Gastroenterol. 2017 Dec 14;23(46):8261-8262. doi: 10.3748/wjg.v23.i46.8261. World J Gastroenterol. 2017. PMID: 29290663 Free PMC article.
References
-
- Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following ‘curative’ surgery for large bowel cancer: II. The rectum and rectosigmoid. Br J Surg. 1984;71:17–20. - PubMed
-
- Bokey EL, Ojerskog B, Chapuis PH, Dent OF, Newland RC, Sinclair G. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg. 1999;86:1164–1170. - PubMed
-
- Cedermark B, Dahlberg M, Glimelius B, Påhlman L, Rutqvist LE, Wilking N. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980–987. - PubMed
-
- Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg. 2007;94:113–118. - PubMed
-
- Shoup M, Guillem JG, Alektiar KM, Liau K, Paty PB, Cohen AM, Wong WD, Minsky BD. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum. 2002;45:585–592. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
